Table 1 Presents data of 15 patients; it is a case series study
No | Gender/age (years) | Recurrent location | Tumor | Tumor site | Microwave use | Follow-up (months) | Function* (Pre-/6 m) | Recurrence or metastasis | Survival |
|---|---|---|---|---|---|---|---|---|---|
1 | M/13 | Femoral diaphyseal | Osteoid osteoma | Local only | Percutaneous ablation | 31 | 24/30 | No | Alive without tumor |
2 | F/39 | Distal radius | Giant cell tumor | Ablation before curettage | 92 | 20/28 | No | ||
3 | F/34 | Proximal humerus | 34 | 21/26 | No | ||||
4 | F/28 | Distal tibia | 24 | 19/26 | No | ||||
5 | M/27 | Distal femur | 44 | 18/27 | No | ||||
6 | F/30 | Distal femur | 30 | 21/27 | No | ||||
7 | M/23 | Proximal femur | Local and lung | 32 | 18/27 | Lung metastasis | Alive with tumor | ||
8 | F/15 | Distal femur | Chondroblastoma | Local only | Ablation before curettage | 33 | 22/26 | No | Alive without tumor |
9 | M/15 | Distal femur | 25 | 23/25 | No | ||||
10 | M/23 | Middle femur | Osteosarcoma | Local and lung | Ablation before resection | 15 | 18/22 | Lung metastasis | Dead of disease |
11 | M/22 | Middle femur | 12 | 16/20 | Lung metastasis | ||||
12 | F/68 | Distal femur | Undifferentiated sarcoma | 29 | 15/22 | Lung metastasis | Alive with tumor | ||
13 | F/69 | Proximal tibia | Liposarcoma metastasis | Local and Multiple metastasis | Ablation before curettage | 12 | 14/17 | Lymphatic metastasis | Dead of disease |
14 | M/12 | Proximal tibia | Osteosarcoma metastasis | Ablation before curettage | 11 | 13/20 | Lung metastasis | ||
15 | M/63 | Proximal humerus | Renal carcinoma metastasis | Percutaneous ablation | 25 | 13/19 | Multiple metastasis | Alive with tumor |